Identifying breast cancer risk loci by global differential allele-specific expression (DASE) analysis in mammary epithelial transcriptome

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Gao, Chuan ^a   Devarajan, Karthik ^a   Zhou, Yan ^a   Slater, Carolyn M ^a   Daly, Mary B ^a   Chen, Xiaowei ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer susceptibility; Differential allele specific expression; DMBT1; SNP array

Indexed keywords

COMPLEMENTARY DNA; DOUBLE STRANDED DNA; TRANSCRIPTOME;

ALLELE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER RISK; CANCER SUSCEPTIBILITY; CANCER TISSUE; CONTROLLED STUDY; DIFFERENTIAL ALLELE SPECIFIC EXPRESSION; DMBT1 GENE; GENE CONTROL; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; ONCOLOGICAL PARAMETERS; PATHOGENESIS; RISK ASSESSMENT; SEQUENCE ANALYSIS; USP6 GENE; ZNF331 GENE;

ALLELES; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC LOCI; GENOTYPE; HUMANS; MAMMARY GLANDS, HUMAN; MUTATION; NEOPLASM PROTEINS; NONSENSE MEDIATED MRNA DECAY; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; RISK; TRANSCRIPTOME; UBIQUITIN THIOLESTERASE;

EID: 84867900315     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-570     Document Type: Article

References (52)

1. Howlader NNA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK. SEER Cancer Statistics Review 1975-2008 2011, National Cancer Institute, Bethesda, MD, USA.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(1):10-29. 10.3322/caac.20138, 22237781.
3. Bove B, Dunbrack RL, Godwin AK. BRCA1, BRCA2, and Hereditary Breast Cancer. Breast Cancer: Prognosis, Treatment and Prevention 2002, 555-624. Marcel Dekker Inc, New York, NY, USA, Pasqualini JR.
4. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266(5182):66-71. 10.1126/science.7545954, 7545954.
5. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994, 265(5181):2088-2090. 10.1126/science.8091231, 8091231.
6. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003, 302(5645):643-646. 10.1126/science.1088759, 14576434.
7. Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. Jama 2006, 295(12):1379-1388. 10.1001/jama.295.12.1379, 16551709.
8. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275(5308):1943-1947. 10.1126/science.275.5308.1943, 9072974.
9. Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M, Easton DF. Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 2005, 97(11):813-822. 10.1093/jnci/dji141, 15928302.
10. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002, 31(1):55-59. 10.1038/ng879, 11967536.
11. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K, et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 2006, 38(11):1239-1241. 10.1038/ng1902, 17033622.
12. Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, Liu X, Jasin M, Couch FJ, Livingston DM. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 2006, 22(6):719-729. 10.1016/j.molcel.2006.05.022, 16793542.
13. Steffen J, Nowakowska D, Niwinska A, Czapczak D, Kluska A, Piatkowska M, Wisniewska A, Paszko Z. Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int J Cancer 2006, 119(2):472-475. 10.1002/ijc.21853, 16770759.
14. Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Knuutila S, Lundan T, Mannermaa A, Borresen-Dale AL, Borg A, Barkardottir RB, et al. RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 2006, 27(8):1593-1599. 3006189, 16474176.
15. Van't Veer LJ, Paik S, Hayes DF, Van't Veer LJ, Paik S, Hayes DF. Gene expression profiling of breast cancer: a new tumor marker. J Clin Oncol 2005, 23(8):1631-1635. 10.1200/JCO.2005.12.005, 15755970.
16. Chen X, Truong TT, Weaver J, Bove BA, Cattie K, Armstrong BA, Daly MB, Godwin AK. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Hum Mutat 2006, 27(5):427-435. 10.1002/humu.20319, 16619214.
17. Chen X, Weaver J, Bove BA, Vanderveer LA, Weil SC, Miron A, Daly MB, Godwin AK. Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk. Hum Mol Genet 2008, 17(9):1336-1348. 10.1093/hmg/ddn022, 18204050.
18. Buckland PR. Allele-specific gene expression differences in humans. Hum Mol Genet 2004, 13 Spec No 2:R255-R260.
19. Song MY, Kim HE, Kim S, Choi IH, Lee JK. SNP-based large-scale identification of allele-specific gene expression in human B cells. Gene 2012, 493(2):211-218. 10.1016/j.gene.2011.11.058, 22178530.
20. Ge B, Pokholok DK, Kwan T, Grundberg E, Morcos L, Verlaan DJ, Le J, Koka V, Lam KC, Gagne V, et al. Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet 2009, 41(11):1216-1222. 10.1038/ng.473, 19838192.
21. Gunderson KL. Whole-genome genotyping on bead arrays. Methods Mol Biol 2009, 529:197-213. 10.1007/978-1-59745-538-1_13, 19381978.
22. Bjornsson HT, Albert TJ, Ladd-Acosta CM, Green RD, Rongione MA, Middle CM, Irizarry RA, Broman KW, Feinberg AP. SNP-specific array-based allele-specific expression analysis. Genome Res 2008, 18(5):771-779. 10.1101/gr.073254.107, 2336807, 18369178.
23. Serre D, Gurd S, Ge B, Sladek R, Sinnett D, Harmsen E, Bibikova M, Chudin E, Barker DL, Dickinson T, et al. Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet 2008, 4(2):e1000006. 10.1371/journal.pgen.1000006, 2265535, 18454203.
24. Tchatchou S, Riedel A, Lyer S, Schmutzhard J, Strobel-Freidekind O, Gronert-Sum S, Mietag C, D'Amato M, Schlehe B, Hemminki K, et al. Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity. Hum Mutat 2010, 31(1):60-66. 10.1002/humu.21134, 19830809.
25. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. The role of site accessibility in microRNA target recognition. Nat Genet 2007, 39(10):1278-1284. 10.1038/ng2135, 17893677.
26. Daelemans C, Ritchie ME, Smits G, Abu-Amero S, Sudbery IM, Forrest MS, Campino S, Clark TG, Stanier P, Kwiatkowski D, et al. High-throughput analysis of candidate imprinted genes and allele-specific gene expression in the human term placenta. BMC Genet 2010, 11:25. 2871261, 20403199.
27. Moran VA. Perera RJ 2012, Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res, Khalil AM.
28. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011, 21(6):354-361. 10.1016/j.tcb.2011.04.001, 21550244.
29. Gunderson KL, Steemers FJ, Ren H, Ng P, Zhou L, Tsan C, Chang W, Bullis D, Musmacker J, King C, et al. Whole-genome genotyping. Methods Enzymol 2006, 410:359-376.
30. Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M. Genetic susceptibility to breast cancer. Mol Oncol 2010, 4(3):174-191. 10.1016/j.molonc.2010.04.011, 20542480.
31. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447(7148):1087-1093. 10.1038/nature05887, 2714974, 17529967.
32. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007, 39(7):870-874. 10.1038/ng2075, 3493132, 17529973.
33. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, Masson G, Jakobsdottir M, Thorlacius S, Helgason A, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007, 39(7):865-869. 10.1038/ng2064, 17529974.
34. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012, 44(3):312-318. 10.1038/ng.1049, 22267197.
35. McCarthy MI, Hirschhorn JN. Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 2008, 17(R2):R156-R165. 10.1093/hmg/ddn289, 2782356, 18852205.
36. Easton DF, Eeles RA. Genome-wide association studies in cancer. Hum Mol Genet 2008, 17(R2):R109-R115. 10.1093/hmg/ddn287, 18852198.
37. Spencer C, Hechter E, Vukcevic D, Donnelly P. Quantifying the underestimation of relative risks from genome-wide association studies. PLoS Genet 2011, 7(3):e1001337. 10.1371/journal.pgen.1001337, 3060077, 21437273.
38. Meyer KB, Maia AT, O'Reilly M, Teschendorff AE, Chin SF, Caldas C, Ponder BA. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 2008, 6(5):e108. 10.1371/journal.pbio.0060108, 2365982, 18462018.
39. Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 2009, 41(8):882-884. 10.1038/ng.403, 2763485, 19561607.
40. Lei H, Hemminki K, Johansson R, Altieri A, Enquist K, Henriksson R, Lenner P, Forsti A. Single nucleotide polymorphisms in the DMBT1 promoter and the progression of breast cancer. Int J Cancer 2007, 120(2):447-449. 10.1002/ijc.22182, 17066405.
41. Blackburn AC, Hill LZ, Roberts AL, Wang J, Aud D, Jung J, Nikolcheva T, Allard J, Peltz G, Otis CN, et al. Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk. Am J Pathol 2007, 170(6):2030-2041. 10.2353/ajpath.2007.060512, 1899446, 17525270.
42. Braidotti P, Nuciforo PG, Mollenhauer J, Poustka A, Pellegrini C, Moro A, Bulfamante G, Coggi G, Bosari S, Pietra GG. DMBT1 expression is down-regulated in breast cancer. BMC cancer 2004, 4:46. 10.1186/1471-2407-4-46, 514551, 15301691.
43. Mollenhauer J, Helmke B, Medina D, Bergmann G, Gassler N, Muller H, Lyer S, Diedrichs L, Renner M, Wittig R, et al. Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis. Genes, Chromosomes & Cancer 2004, 39(3):185-194. 10.1002/gcc.10309, 23229310.
44. Tycko B. Mapping allele-specific DNA methylation: a new tool for maximizing information from GWAS. Am J Hum Genet 2010, 86(2):109-112. 10.1016/j.ajhg.2010.01.021, 2820186, 20159108.
45. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer 2004, 4(3):177-183. 10.1038/nrc1299, 2665285, 14993899.
46. Klee EW, Hoppman-Chaney NL, Ferber MJ. Expanding DNA diagnostic panel testing: is more better?. Expert Rev Mol Diagn 2011, 11(7):703-709. 10.1586/erm.11.58, 21902532.
47. Godwin AK, Vanderveer L, Schultz DC, Lynch HT, Altomare DA, Buetow KH, Daly M, Getts LA, Masny A, Rosenblum N, et al. A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. Am J Hum Genet 1994, 55(4):666-677. 1918278, 7942844.
48. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162(1):156-159.
49. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA. Circos: an information aesthetic for comparative genomics. Genome Res 2009, 19(9):1639-1645. 10.1101/gr.092759.109, 2752132, 19541911.
50. Wagner JR, Ge B, Pokholok D, Gunderson KL, Pastinen T, Blanchette M. Computational analysis of whole-genome differential allelic expression data in human. PLoS Comput Biol 2010, 6(7):e1000849. 10.1371/journal.pcbi.1000849, 2900287, 20628616.
51. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A practical and powerful approach to multiple testing. J R Stat Soc 1995, 57:289-300.
52. Team RDC. R: A language and environment for statistical computing 2005, In. Edited by Computing RFfS, Vienna.